new (March 24th) report in Clinical Cancer Research, a journal of the American Association for Cancer Research, shows that Omega-3 fatty acids appear protective against advanced prostate cancer.
Dr. John S. Witte, Ph.D., professor of epidemiology and biostatistics at the University of California San Francisco, says that previous research has shown protection against prostate cancer, but that this is one of the first studies to show protection against advanced prostate cancer.
Vitamin D and the epidemiology of prostate cancer.
Schwartz GG.
Semin Dial. 2005 Jul-Aug;18(4):276-89. Review.
PMID: 16076349
DOI: 10.1111/j.1525-139X.2005.18403.x
Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate.
Falsaperla M, Morgia G, Tartarone A, Ardito R, Romano G.
Eur Urol. 2005 Apr;47(4):449-54; discussion 454-5. Epub 2005 Jan 19.
PMID: 15774240
doi:10.1016/j.eururo.2004.12.001
Flaig TW, Su LJ, Harrison G, Agarwal R, Glode LM.
Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.
Int J Cancer. 2007 Jan 17; [Epub ahead of print]
PMID: 17230508 [PubMed - as supplied
Singh RP, Agarwal R.
Prostate cancer chemoprevention by silibinin: bench to bedside.
Mol Carcinog. 2006 Jun;45(6):436-42. Review.
PMID: 16637061 [PubMed - indexed for MEDLINE]
Singh RP, Agarwal R.
Prostate cancer prevention by silibinin.
Curr Cancer Drug Targets. 2004 Feb;4(1):1-11. Review.
PMID: 14965263 [PubMed - indexed for MEDLINE]
Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation.
Cao W, Yacoub S, Shiverick KT, Namiki K, Sakai Y, Porvasnik S, Urbanek C, Rosser CJ.
Prostate. 2008 Aug 1;68(11):1223-31.
PMID: 18465755
DOI: 10.1002/pros.20788
Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg).\nNimptsch K, Rohrmann S, Linseisen J.\nAm J Clin Nutr. 2008 Apr;87(4):985-92.\nPMID: 18400723
Jourdain C, Tenca G, Deguercy A, Troplin P, Poelman D. In-vitro effects of polyphenols from cocoa and beta-sitosterol on the growth of human prostate cancer and normal cells.
Eur J Cancer Prev. 2006 Aug;15(4):353-61.
PMID: 16835506 [PubMed - indexed fo
ScienceDaily (Sep. 1, 2005) - STANFORD, Calif. - The growth of prostate cancer cells can be halted by combining a form of vitamin D, available only by prescription, with low doses of an over-the-counter painkiller, researchers at the Stanford University School of Medicine have found. The combination reduced prostate cancer cell growth in a laboratory dish by up to 70 percent, according to the findings, published in the Sept. 1 issue of Cancer Research.